Research Reports
Veeda Clinical Research Unlisted Shares

DMAT
PUBLIC LIMITED
Price Chart
High
₹560
Low
₹467
Return
-7.52%
ISIN
INE01HQ01026
Face Value
2
Total Shares
6,57,77,495
Market Cap
2,940.25 Cr
Profit After Tax
0 None
Total Revenue
0 None
Sector
Health Care
Sub-sector
Pharmaceuticals
Category
Pre IPO
Explore in-depth financial analysis, performance metrics, and key disclosures.
News
Articles
Videos
Veeda Clinical Research: CX Partners-led consortium looks to sell majority stake, eyes $600 mn -$650 mn valuation
28 Apr 2024
• Moneycontrol
Veeda Clinical Research buys European CRO Heads for an undisclosed sum
25 Mar 2024
• Business Standard
CX Partners Backed Veeda Gets SEBI Nod For IPO
27 Dec 2021
• VC Circle